C-kit Protein Expression and Mutation Analysis in Adenoid Cystic Carcinomas

샘낭암종에서의 C-kit 단백 발현 및 돌연변이 분석

  • Cho Kyung-Ja (Departments of Pathology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Choi Jene (Departments of Pathology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Kim Sang-Yoon (Departments of Otorhinolaryngology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Nam Soon-Yuhl (Departments of Otorhinolaryngology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Choi Seung-Ho (Departments of Otorhinolaryngology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Kim Sung-Bae (Departments of Hematooncology, University of Ulsan College of Medicine, Asan Medical Center)
  • 조경자 (울산대학교 의과대학 서울아산병원 병리과학교실) ;
  • 최진 (울산대학교 의과대학 서울아산병원 병리과학교실) ;
  • 김상윤 (울산대학교 의과대학 서울아산병원 이비인후과학교실) ;
  • 남순열 (울산대학교 의과대학 서울아산병원 이비인후과학교실) ;
  • 최승호 (울산대학교 의과대학 서울아산병원 이비인후과학교실) ;
  • 김성배 (울산대학교 의과대학 서울아산병원 종양혈액내과학교실)
  • Published : 2003.11.01

Abstract

Objectives: To document the incidence and pattern of c-kit protein expression & mutation in adenoid cystic carcinomas. Materials and Methods: Twenty-five cases of adenoid cystic carcinomas of the major and minor salivary glands and the upper and lower respiratory tract were subjected to the immunohistochemical study for ckit(CD117 ; Dako). Nineteen cases of them were analyzed for mutations in exon 11 and exon 17 by PCR-SSCP, and in cases of need, by DNA sequencing. Results: Twenty-three cases (92%) showed c-kit expression, but none showed mutations in exon 11 and exon 17. The expression was restricted to the inner luminal cells in all tubular types and most of cribriform adenoid cystic carcinomas, while the staining was diffuse in all solid variants and two cribriform types. Conclusion: C-kit expression was common in adenoid cystic carcinomas, regardless of their origins. Although genetic bases await further studies, a clinical trial of tyrosine kinase inhibitors in adenoid cystic carcinomas, especially in solid variants, is considered encouraging.

Keywords

References

  1. Matsuda R, Takahashi T, Nakamura S, et al : Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathoi. 1993 ; 142 : 339-346
  2. Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C : Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem. 1994 ; 42 : 1417-1425 https://doi.org/10.1177/42.11.7523489
  3. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M : Mutations in exon 11 of c-kit occur preferentially in malignantversus benign gastrointestinal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol. 1999 ; 154 : 53-60 https://doi.org/10.1016/S0002-9440(10)65250-9
  4. Arber DA, Tamayo R, Weiss LM : Paraffin section detection of the c-kit gene product(CD117) in humantissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998 ; 29 : 498-504 https://doi.org/10.1016/S0046-8177(98)90066-1
  5. Sawyers CL : Rational therapeutic intervention in cancer : kinases as drug targets. Curr Opinions Gene Dev. 2002 ; 12 : 111-115 https://doi.org/10.1016/S0959-437X(01)00273-8
  6. Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr : KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol. 1999 ; 12 : 956-960
  7. Jeng YM, Lin CY, Hsu HC : Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett. 2000 ; 154 : 107-111 https://doi.org/10.1016/S0304-3835(00)00387-6
  8. Penner CR, Folpe AL, Budnick SD : C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol. 2002 ; 15 : 687-691 https://doi.org/10.1097/01.MP.0000018973.17736.F8
  9. Edwards PC, Bhuiya T, Kelsch RD : C-kit expression in the salivaryglandneoplasmadenoidcysticcarcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol: 2003 ; 95 : 586-593 https://doi.org/10.1067/moe.2003.31
  10. Smithey BE, Pappo AS, Hill DA : C-kit expression in pediatric solid tumors : a comparative immunohistochemical study. Am J Surg Pathol. 2002 ; 26 : 486-492 https://doi.org/10.1097/00000478-200204000-00011
  11. Scotlandi K, Manara MC, Strammiello R, et al : C-kit receptor expression in Ewing's sarcoma : lack of prognostic value but therapeutic targeting opportunities in appropriate conditions. J Clin Oncol. 2003 ; 15 : 1952-1960
  12. Lu CS, Kashima K, Daa T, Yokoyama S, Yanagisawa S, Nakayama I : Immunohistochemical study of the distribution of endogenous biotin and biotin-bindingenzymes in ductal structures of salivary gland tumours. J Oral Pathol Med. 2000 ; 29 : 445-451 https://doi.org/10.1034/j.1600-0714.2000.290905.x
  13. Bussilati G, Gugliotta P, Volante M, Pace M, Papotti M : Retrieved endogenous biotin : a novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopothology. 1997 ; 31 :400-407 https://doi.org/10.1046/j.1365-2559.1997.3020895.x
  14. Dagher R, Cohen M, Williams G, et al : Approval summary : imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res. 2002 ; 8 : 3034-3038
  15. Chen H, Isozaki K, Kinoshita K, et al : lmatinib inhibits various types of activating mutant kit found in gastrointestinal stromal tumors. Int J Cancer. 2003 ; 105 : 130-135 https://doi.org/10.1002/ijc.11025
  16. Zennati Y, De Sepulveda P, Feger F, et al : Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene. 2003 ; 22 : 660-664. https://doi.org/10.1038/sj.onc.1206120
  17. Bauer S, Corless CL, Heinrich MC, et al : Response to imatinib mesylate of a gastointestinal stromal tumor with very low expression of KIT. Cancer Chemother Pharmacol. 2003 ; 51 : 261-265